More research should be conducted to test the hypothesis on the inhibitory mechanism of breast cancer cells on hPL expression and the immunoexpression of hPL in mammary carcinoma with syncytiotrophoblastic differentiation. The gene discussed is LGALS1; the disease is breast carcinoma.